Cosmos(SZ:002133)2025-04-29 07:55Financial Performance - The company's revenue for Q1 2025 was ¥865,458,115.95, a decrease of 35.48% compared to ¥1,341,350,963.33 in the same period last year[3] - The net profit attributable to shareholders was -¥38,161,346.94, representing a decline of 1,233.24% from ¥3,367,456.76 year-on-year[3] - The basic and diluted earnings per share were both -¥0.0493, a decrease of 1,246.51% from ¥0.0043 in the same period last year[3] - The company reported a net profit of -36,737,808.93 yuan for the current period, compared to a net profit of 35,551,817.51 yuan in the previous period, indicating a significant decline[27] - Basic and diluted earnings per share for the current period were -0.0493, compared to 0.0043 in the previous period[30] - The company experienced a decrease in sales revenue from 1,197,431,675.76 yuan to 845,939,686.30 yuan, reflecting a decline in business activity[31] - The company reported a total profit of -32,955,321.24 yuan, compared to 59,916,427.22 yuan in the previous period, indicating a substantial loss[27] Cash Flow and Liquidity - The net cash flow from operating activities improved to ¥72,112,375.92, a significant increase of 131.24% compared to -¥230,833,359.94 in the previous year[3] - Cash flow from operating activities generated a net cash inflow of 72,112,375.92 yuan, a recovery from a net outflow of -230,833,359.94 yuan in the previous period[31] - Total cash and cash equivalents at the end of the period were 1,017,992,455.11 yuan, down from 1,577,351,765.80 yuan in the previous period[34] - Cash and cash equivalents decreased to CNY 1,255,935,284.96 from CNY 1,505,507,093.78, representing a decline of 16.5%[19] - Cash flow from financing activities resulted in a net outflow of -379,716,871.58 yuan, compared to -94,682,600.91 yuan in the previous period[34] - The company received cash from the issuance of shares amounting to 980,000.00 yuan, an increase from 735,000.00 yuan in the previous period[34] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,322,556,920.31, down 6.74% from ¥9,996,074,864.67 at the end of the previous year[3] - Total assets decreased to CNY 9,322,556,920.31 from CNY 9,996,074,864.67, a reduction of 6.8%[21] - Total liabilities decreased to CNY 6,266,842,171.86 from CNY 6,867,177,307.29, a decline of 8.7%[23] - The equity attributable to shareholders decreased by 1.31% to ¥2,873,905,274.20 from ¥2,912,066,621.14 at the end of the last year[3] Operational Insights - The company reported a significant decline in gross profit margin compared to the previous year, impacting net profit[7] - The company has not disclosed any new product developments or market expansion strategies in this report[3] - Total operating revenue for Q1 2025 was CNY 866,667,354.46, a decrease of 35.4% compared to CNY 1,342,549,712.13 in the same period last year[25] - Total operating costs for Q1 2025 were CNY 910,149,375.43, down 32.3% from CNY 1,344,689,015.87 year-over-year[25] - Inventory as of March 31, 2025, was CNY 5,380,585,728.88, down 8.5% from CNY 5,884,723,784.10[19] Strategic Plans - The company plans to enhance cash flow management in its real estate business and expand its silver-haired health care business to create a second growth curve[15] - The company aims to actively conduct cash dividends based on its operational and financial conditions, enhancing investor confidence[15] - The company is committed to improving information disclosure quality and optimizing investor relations management[15] - The 2025 valuation enhancement plan focuses on core business and cost structure optimization to drive high-quality development[15] Non-Recurring Items - Non-recurring gains and losses totaled ¥1,428,699.01 for the reporting period[5] - The company incurred financial expenses of 24,709,220.21 yuan, an increase from 20,024,108.18 yuan in the previous period[27] - Investment activities generated a net cash inflow of 2,293,840.70 yuan, down from 57,891,883.96 yuan in the previous period[31]